FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945762505> ?p ?o ?g. }

• W2945762505 endingPage "1749" @default.
• W2945762505 startingPage "1729" @default.
• W2945762505 abstract "Valproic acid (VPA) is suggested to be therapeutically beneficial in combination with interferon-alpha (IFNα) in various cancers. Therefore, we examined IFNα and VPA alone and in combinations in selected AML models, examining immune regulators and intracellular signaling mechanisms involved in phospho-proteomics.The anti-leukemic effects of IFNα and VPA were examined in vitro and in vivo. We mapped the in vitro phosphoprotein modulation by IFNα-2b and human IFNα-Le in MOLM-13 cells by IMAC/2D DIGE/MS analysis and phospho-flow cytometry, and in primary healthy and AML patient-derived PBMCs by CyTOF. In vivo, IFNα-Le and VPA efficacy were investigated in the immunodeficient NOD/Scid IL2γ-/- MOLM-13Luc+ mouse model and the syngeneic immunocompetent BNML rat model.IFNα-2b and IFNα-Le differed in the modulation of phospho-proteins involved in protein folding, cell stress, cell death and p-STAT6 Y641, whereas VPA and IFNα-Le shared signaling pathways involving phosphorylation of Akt (T308), ERK1/2 (T202/T204), p38 (T180/Y182), and p53 (S15). Both IFNα compounds induced apoptosis synergistically with VPA in vitro. However, in vivo, VPA monotherapy increased survival, but no benefit was observed by IFNα-Le treatment. CyTOF analysis of primary human PBMCs indicated that lack of immune-cell activation could be a reason for the absence of response to IFNα in the animal models investigated.IFNα-2b and IFNα-Le showed potent and synergistic anti-leukemic effects with VPA in vitro but not in leukemic mouse and rat models in vivo. The absence of IFNα immune activation in lymphocyte subsets may potentially explain the limited in vivo anti-leukemic effect of IFNα-monotherapy in AML." @default.
• W2945762505 created "2019-05-29" @default.
• W2945762505 creator A5000870281 @default.
• W2945762505 creator A5006949480 @default.
• W2945762505 creator A5021294750 @default.
• W2945762505 creator A5040305939 @default.
• W2945762505 creator A5050577587 @default.
• W2945762505 creator A5057088387 @default.
• W2945762505 creator A5081654775 @default.
• W2945762505 creator A5090469110 @default.
• W2945762505 date "2019-05-20" @default.
• W2945762505 modified "2023-10-14" @default.
• W2945762505 title "Modulation of phospho-proteins by interferon-alpha and valproic acid in acute myeloid leukemia" @default.
• W2945762505 cites W1605755748 @default.
• W2945762505 cites W1631320694 @default.
• W2945762505 cites W1750408391 @default.
• W2945762505 cites W1784344499 @default.
• W2945762505 cites W1882534318 @default.
• W2945762505 cites W1966327132 @default.
• W2945762505 cites W1970259496 @default.
• W2945762505 cites W1971113323 @default.
• W2945762505 cites W1975746053 @default.
• W2945762505 cites W1979526175 @default.
• W2945762505 cites W1981662104 @default.
• W2945762505 cites W1983866601 @default.
• W2945762505 cites W2003886702 @default.
• W2945762505 cites W2008055344 @default.
• W2945762505 cites W2008232752 @default.
• W2945762505 cites W2015886726 @default.
• W2945762505 cites W2027168511 @default.
• W2945762505 cites W2038426170 @default.
• W2945762505 cites W2040668893 @default.
• W2945762505 cites W2041419269 @default.
• W2945762505 cites W2045772382 @default.
• W2945762505 cites W2056212041 @default.
• W2945762505 cites W2056240256 @default.
• W2945762505 cites W2058188142 @default.
• W2945762505 cites W2060043425 @default.
• W2945762505 cites W2068700346 @default.
• W2945762505 cites W2070012795 @default.
• W2945762505 cites W2072493871 @default.
• W2945762505 cites W2080167853 @default.
• W2945762505 cites W2086651719 @default.
• W2945762505 cites W2088195663 @default.
• W2945762505 cites W2094170162 @default.
• W2945762505 cites W2097863827 @default.
• W2945762505 cites W2117446917 @default.
• W2945762505 cites W2119885778 @default.
• W2945762505 cites W2128327076 @default.
• W2945762505 cites W2133970739 @default.
• W2945762505 cites W2137906256 @default.
• W2945762505 cites W2141939962 @default.
• W2945762505 cites W2153640125 @default.
• W2945762505 cites W2156645168 @default.
• W2945762505 cites W2160050995 @default.
• W2945762505 cites W2160907388 @default.
• W2945762505 cites W2164130643 @default.
• W2945762505 cites W2179466343 @default.
• W2945762505 cites W2340128484 @default.
• W2945762505 cites W2419605286 @default.
• W2945762505 cites W2428790343 @default.
• W2945762505 cites W2554720319 @default.
• W2945762505 cites W2559537906 @default.
• W2945762505 cites W2630731228 @default.
• W2945762505 cites W312480887 @default.
• W2945762505 cites W3134708772 @default.
• W2945762505 cites W3135057003 @default.
• W2945762505 cites W4241879183 @default.
• W2945762505 doi "https://doi.org/10.1007/s00432-019-02931-1" @default.
• W2945762505 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6571093" @default.
• W2945762505 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31111215" @default.
• W2945762505 hasPublicationYear "2019" @default.
• W2945762505 type Work @default.
• W2945762505 sameAs 2945762505 @default.
• W2945762505 citedByCount "8" @default.
• W2945762505 countsByYear W29457625052019 @default.
• W2945762505 countsByYear W29457625052020 @default.
• W2945762505 countsByYear W29457625052021 @default.
• W2945762505 countsByYear W29457625052022 @default.
• W2945762505 countsByYear W29457625052023 @default.
• W2945762505 crossrefType "journal-article" @default.
• W2945762505 hasAuthorship W2945762505A5000870281 @default.
• W2945762505 hasAuthorship W2945762505A5006949480 @default.
• W2945762505 hasAuthorship W2945762505A5021294750 @default.
• W2945762505 hasAuthorship W2945762505A5040305939 @default.
• W2945762505 hasAuthorship W2945762505A5050577587 @default.
• W2945762505 hasAuthorship W2945762505A5057088387 @default.
• W2945762505 hasAuthorship W2945762505A5081654775 @default.
• W2945762505 hasAuthorship W2945762505A5090469110 @default.
• W2945762505 hasBestOaLocation W29457625051 @default.
• W2945762505 hasConcept C150903083 @default.
• W2945762505 hasConcept C203014093 @default.
• W2945762505 hasConcept C207001950 @default.
• W2945762505 hasConcept C2776178377 @default.
• W2945762505 hasConcept C2778690821 @default.
• W2945762505 hasConcept C2909179924 @default.
• W2945762505 hasConcept C502942594 @default.
• W2945762505 hasConcept C86803240 @default.

• next